Search Results - A. V. Matveev

Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers by A. E. Krasheninnikov, A. V. Matveev, S. D. Marchenko

Connect to this object online.

Possibilities for the use of tofacitinib in patients with COVID-19 by A. V. Matveev, Yu. Yu. Kiselev, D. A. Sychev

Connect to this object online.

Rationality of routine clinical use of olokizumab in COVID-19 by V. M. Tsvetov, A. V. Matveev, D. A. Sychev

Connect to this object online.

Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice by A. V. Matveev, A. E. Krasheninnikov, A. Yu. Zelinskaya

Connect to this object online.

Current and future use of favipiravir in patients with COVID-19 by A. V. Matveev, Yu. Yu. Kiselev, D. A. Sychev

Connect to this object online.

Current and future use of vitamin D₃ in patients with COVID-19 by I. N. Sychev, A. V. Matveev, D. A. Sychev

Connect to this object online.

Possibilities for the use of anakinra in COVID-19 by V. A. Otdelenov, A. V. Matveev, D. A. Sychev

Connect to this object online.

Current and future use of colchicine in patients with COVID-19 by Yu. Yu. Kiselev, A. V. Matveev, D. A. Sychev

Connect to this object online.

Current and future use of angiotensin II receptor blockers in patients with COVID-19 by A. V. Matveev, V. A. Otdelenov, D. A. Sychev

Connect to this object online.

COMPARATIVE REVIEW OF METHODOLOGIES FOR ESTIMATING THE COST OF ADVERSE DRUG REACTIONS IN THE RUSSIAN FEDERATION AND BRAZIL by G. I. Syraeva, A. S. Kolbin, A. V. Matveev, V. S. Panezhina

Connect to this object online.

Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017-2022 by A. V. Matveev, S. V. Glagolev, K. N. Koryanova, D. A. Sychev

Connect to this object online.

Retrospective Analysis of Spontaneous Reports of Fatal Adverse Reactions Associated with Lidocaine by A. V. Matveev, E. I. Konyaeva, E. A. Egorova, A. M. Beitullaev

Connect to this object online.

ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016) by A. V. Matveev, A. Е. Krasheninnikov, E. A. Egorova, E. I. Konyaeva

Connect to this object online.

Spontaneous Reporting Method Used for Safety Evaluation of Nonsteroidal Anti-Inflammatory Drugs and Paracetamol Products, Based on Assessment of Data from Periodic Reports by A. V. Matveev, E. A. Egorova, A. E. Krasheninnikov, E. I. Konyaeva

Connect to this object online.

INVESTIGATION OF MEDICALLY INDUCED SKIN REACTIONS BASED ON THE ANALYSIS OF REPORTS OF ADVERSE DRUG REACTIONS IN THE REPUBLIC OF CRIMEA (FROM 2009 TO 2016) by A. V. Matveev, А. E. Krasheninnikov, E. A. Egorova, Е. I. Konyaeva

Connect to this object online.

Differences between the European and Eurasian Good Pharmacovigilance Practices by A. V. Matveev, A. E. Krasheninnikov, E. A. Matveeva, B. K. Romanov

Connect to this object online.

Study of Safety of Medicinal Products in Pregnant Women in Crimea by A. V. Matveev, E. A. Egorova, A. E. Krasheninnikov, E. I. Konyaeva

Connect to this object online.

Review of publications on drug-related problems investigations in osteoporosis patients by E. A. Egorova, A. M. Beitullaev, A. V. Matveev, K. N. Koryanova

Connect to this object online.

Retrospective analysis of adverse drug reaction reporting forms associated with penicillin family antibiotics (pcne-drp 9.0) based on drug-related approach by A. V. Matveev, A. E. Krasheninnikov, E. A. Egorova, E. I. Koniaeva

Connect to this object online.

Monitoring of safety using favipiravir: risk management of adverse drug reactions in clinical practice by Yu. Yu. Kiselev, A. V. Matveev, K. B. Mirzaev, D. A. Sychev

Connect to this object online.